Bausch Health Companies Inc., a global, diversified pharmaceutical company, along with its global aesthetic business, Solta Medical, announced the successful completion of the acquisition of Wuhan Shibo Zhenmei Technology Co., Ltd., consisting of the Shibo group’s aesthetics distribution business. The Shibo group has served as Solta Medical’s trusted distribution partner over the past decade. Effective December 1, 2025, Wuhan Shibo Zhenmei Technology Co., Ltd. became a wholly owned subsidiary of Solta Medical in China, assuming full responsibility for the distribution of Solta Medical’s products, including Thermage® FLX, as well as other aesthetic devices in the Chinese market.
Thomas J. Appio, Chief Executive Officer of Bausch Health, stated, “This acquisition expands Solta Medical’s geographical reach and market scale in China. By leveraging an existing distribution network and local knowledge, Solta Medical can immediately gain access to the large customer base to drive future revenue and market share growth. Solta Medical delivers premium offerings, and we look forward to building on our foundation of success and deepening our commitment to excellence in China.”
This acquisition provides Solta Medical with an enhanced ability to address increasing market demand for aesthetics treatments through localized solutions and proven technologies. Building on a longstanding partnership, this acquisition reinforces Solta Medical’s focus to gain direct insight into customer needs, preferences, and service in the China market.
Jiny Kim, Senior Vice President, Solta Medical, commented, “The Shibo group has been integral to the success of Thermage in China for more than a decade. Integrating their team into Solta Medical allows us to build on that trust and deliver even greater value-accelerating innovation by being closer to our customers, enhancing service, and ensuring patients continue to receive high-quality treatments.”
Belinda Bao, Vice President, General Manager, Solta China, added, “This step puts Solta Medical in a stronger position as a growth driver for Bausch Health. We are now able to move quicker in the Chinese market and focus on delivering quality results with trusted technologies like Thermage.”
This strategic acquisition demonstrates Bausch Health’s ongoing commitment to advancing global aesthetics. By delivering reliable and innovative solutions, the company aims to support both providers and the patients they serve in the rapidly evolving aesthetics market.
